I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Unique structure of ozoralizumab, a trivalent anti-TNFα NAN..:
Masanao Kyuuma
;
Ayaka Kaku
;
Chiemi Mishima-Tsumagari
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1149874/full. , 2023
Link:
https://doi.org/10.3389/fimmu.2023.1149874
RT Journal T1
Unique structure of ozoralizumab, a trivalent anti-TNFα NANOBODY® compound, offers the potential advantage of mitigating the risk of immune complex-induced inflammation
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:93e7dbb80a1a452d968da965f61623be&Exemplar=1&LAN=DE A1 Masanao Kyuuma A1 Ayaka Kaku A1 Chiemi Mishima-Tsumagari A1 Bunichiro Ogawa A1 Mayumi Endo A1 Yunoshin Tamura A1 Kei-ichiro Ishikura A1 Masashi Mima A1 Yutaka Nakanishi A1 Yasuyuki Fujii PB Frontiers Media S.A. YR 2023 K1 tumor necrosis factor K1 VHH K1 rheumatoid arthritis K1 injection site reaction K1 immunogenicity K1 Fcγ receptor K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1149874/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1149874 DO https://doi.org/10.3389/fimmu.2023.1149874 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)